Skip to content

Cash ratio at other companies

Eli Lilly logo
Eli LillyLLY
0.1×0.0×
Amgen logo
AmgenAMGN
0.0×
Altimmune logo
AltimmuneALT
8.6×+3.6×
Viking Therapeutics logo
Viking TherapeuticsVKTX
1.1×-0.8×
Wave Life Sciences logo
Wave Life SciencesWVE
10.9×+8.1×
Prime Medicine logo
Prime MedicinePRME
2.1×-0.9×

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Calculated from Vivani Medical’s reported figures.

Based on the most recent quarter.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's cash ratio?
Vivani Medical (VANI) reported cash ratio of 2.8× in Q1 2026.
How has Vivani Medical's cash ratio changed year-over-year?
Vivani Medical's cash ratio increased by 44.3% year-over-year, from 1.9× to 2.8×.
What is the long-term trend for Vivani Medical's cash ratio?
Over 5 years (2020 to 2025), Vivani Medical's cash ratio has grown at a 30.9% compound annual growth rate (CAGR), from 0.6× to 2.3×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.